Mission

Our core focus is Instant Bioanalysis — achieving early, on-site, in-situ, and non-destructive acquisition of biological information. To address challenges in complex biological matrices, limited pretreatment methods, severe signal attenuation, and reliance on sophisticated equipment, we have built a progressive research framework spanning from underlying mechanisms to clinical system applications.

Demands for Bioanalysis — Rapid Testing, Disease Control, Precision Medicine
Driving demands for instant bioanalysis across rapid testing, disease control, and precision medicine.
Research Framework
01

Signal Transduction — Luminescence Kinetic Regulation

At the signal transduction level, we dedicate our efforts to novel luminescence kinetic regulation mechanisms to break the intrinsic limits of fluorescence quantum yield. This efficiently converts weak biological recognition events into strong physical signals, laying a solid physical foundation for ultra-sensitive detection.

FluorescenceQuantum YieldLuminescenceSignal Enhancement
Signal Transduction — Luminescence Kinetic Regulation
02

Signal Readout — Chemical Labeling & Probe Design

Building upon signal enhancement mechanisms, we explore new chemical labeling strategies. Through rational design and intelligent prediction of probes, excitation efficiency and optical readability in complex backgrounds are optimized, resolving instrumental bottlenecks to ensure signals are both "accurately measured" and "easily read."

Chemical ProbesMolecular DesignOptical ReadoutAI-assisted Design
Signal Readout — Chemical Labeling and Probe Design
03

Clinical Applications — Phenotypic Profiling Systems

High-performance signal systems are integrated into innovative analytical methods, achieving a leap from single-dimensional concentration analysis to multidimensional phenotypic profiling. This completes the transition from laboratory technology to complex clinical applications.

Clinical DiagnosticsPhenotypic ProfilingPoint-of-CarePrecision Medicine
Clinical Applications — Commercialization and Key Publications
Funding & Grants

Lab Grants

Projects led by Bo Zhang as PI, or obtained by lab members (postdoc / research assistant professor).

2025

Rapid detection and traceability of antibiotic resistance genes using novel nanomaterials

Shenzhen Fundamental Research Fund  ·  PI: Bo Zhang

2024

Multiple nucleic acid amplification-free point-of-care analysis method research and application demonstration

Shenzhen Medical Research Special Fund  ·  PI: Bo Zhang

2024

Amplification-free multiplex nucleic acid detection strategy with photocatalytic proximity labeling and plasmonic material

National Natural Science Foundation of China  ·  PI: Research Assistant Professor

2023

Employment Oriented Teaching Reform for Biomedical Engineering

Southern University of Science and Technology  ·  PI: Bo Zhang

2023

Plasmonic-based Multiplexed Nucleic Acids Detection Platform for Diagnosis of Pathogens

National Natural Science Foundation of China  ·  PI: Bo Zhang

2022

Plasmonic-based SARS-CoV-2 variants detection platform

Guangdong Basic and Applied Basic Research Foundation  ·  PI: Bo Zhang

2022

Carbon Nanotubes/Graphene-based Device for Environmental Virus Detection

Innovative Projects of General Universities of Guangdong Provincial Education Department  ·  PI: Research Assistant Professor

2021

Investigation of Novel Asymmetric Transfer Hydrogenation Catalyst and Implementation in Asymmetric Synthesis of Non-natural Sugar Alcohols and Corresponding Analogues

Shenzhen Fundamental Research Fund  ·  PI: Research Assistant Professor

2020

Magnetic Nanoparticles-based Cell-free Fetal DNA Enrichment from Maternal Plasma

China Postdoctoral Science Foundation  ·  Postdoctoral Researcher

2020

Plasmonic-based Multiplexed SARS-CoV-2 Diagnostic Platform

China Postdoctoral Science Foundation  ·  Postdoctoral Researcher

2019

Novel magnetic nanomaterials for non-invasive prenatal testing

Shenzhen Fundamental Research Fund  ·  PI: Bo Zhang

Funding agencies — NSFC, Guangdong Province, Shenzhen STCI, SMART

Prior to SUSTech

Grants obtained during industry (Nirmidas Biotech) and doctoral training (Stanford University). Listed for reference.

2016

A Nanoscale Plasmonic-Gold Platform for Specific Diagnosis of Zika and Differentiation from other Flavivirus Infections

National Institute of Health Grant  ·  Nirmidas Biotech

2015

Plasmonic-based multiplexed platform for Diagnosis and Screening of Type 1 Diabetes and related Auto-Immune Diseases

National Institute of Health Grant  ·  Nirmidas Biotech

2013

Nano-Engineered Plasmonic Chip for Monitoring of Novel T1D Biomarkers

Juvenile Diabetes Research Foundation Grant  ·  Stanford University (Ph.D.)

2013

Multi-color Hemagglutinin Peptide Microarray on Novel NIR Fluorescence Enhancing Plasmonic Chips

Stanford Bio-X Interdisciplinary Graduate Fellowship  ·  Stanford University (Ph.D.)

2013

Nano-engineered plasmonic chip for Point-of-Care diagnosis of type 1 diabetes

Institute for Immunity, Transplantation, and Infection Seed Grant  ·  Stanford University (Ph.D.)

2013

A new protein microarray platform on plasmonic gold substrate

Stanford Spectrum Pilot Grant Program  ·  Stanford University (Ph.D.)